VCP
MRK icon

Verus Capital Partners’s Merck MRK Stock Holding History

Verus Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
7,818
-560
-7% -$65.5K 0.05% 197
2026
Q1 		$1.01M Buy
8,378
+329
+4% +$38K 0.07% 172
2025
Q4 		$847K Sell
8,049
-778
-9% -$73K 0.06% 187
2025
Q3 		$741K Buy
8,827
+1,038
+13% +$85.5K 0.06% 181
2025
Q2 		$617K Sell
7,789
-72
-0.9% -$5.72K 0.05% 186
2025
Q1 		$706K Buy
7,861
+104
+1% +$9.71K 0.07% 159
2024
Q4 		$772K Sell
7,757
-311
-4% -$32.1K 0.07% 154
2024
Q3 		$918K Sell
8,068
-169
-2% -$20.1K 0.09% 138
2024
Q2 		$1.02M Buy
8,237
+1,170
+17% +$151K 0.11% 121
2024
Q1 		$932K Buy
7,067
+174
+3% +$21.4K 0.1% 123
2023
Q4 		$751K Buy
6,893
+1,027
+18% +$107K 0.09% 128
2023
Q3 		$604K Buy
5,866
+1,228
+26% +$132K 0.08% 136
2023
Q2 		$535K Buy
4,638
+279
+6% +$31.7K 0.08% 152
2023
Q1 		$464K Buy
4,359
+201
+5% +$21.7K 0.07% 162
2022
Q4 		$461K Sell
4,158
-57
-1% -$5.83K 0.09% 152
2022
Q3 		$363K Buy
4,215
+12
+0.3% +$1.07K 0.07% 186
2022
Q2 		$383K Sell
4,203
-1,436
-25% -$127K 0.08% 189
2022
Q1 		$488K Buy
+5,639
New +$445K 0.08% 178
2020
Q1 		$197K Buy
2,679
+826
+45% +$64.9K 0.06% 198
2019
Q4 		$161K Buy
+1,853
New +$152K 0.05% 270

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verus Capital Partners's MRK Position: Q2 2026 in Review

Verus Capital Partners reduced its Merck (MRK) stake by 6.7% in Q2 2026, selling an estimated $65.5K and leaving 7,818 shares worth $1M. The position accounts for 0.05% of the portfolio, ranked #197.

Verus Capital Partners first reported a position in MRK in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.02M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Verus Capital Partners held 7,818 shares of Merck worth $1M as of Q2 2026.
  • Verus Capital Partners sold 560 Merck shares in Q2 2026, an estimated $65.5K.
  • Merck made up 0.05% of Verus Capital Partners's portfolio in Q2 2026, its #197 holding.
  • Verus Capital Partners first reported a position in Merck in Q4 2019 and has held it in 20 quarters since.
  • Verus Capital Partners's Merck position peaked at $1.02M in Q2 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.